Info banner

A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Tag: obesity

12 posts found

Medmonitor

White House Announces Deal to Expand Access to GLP-1 Medications

Qualifying CMS patients could pay as little as $50 a month for Ozempic or Wegovy.

Clinical Insights

JAMA Study Notes Possible Cardiovascular Benefits for GLP-1 Antagonists

Patients taking semaglutide or tirzepatide had a more than 40% lower risk of hospitalization for heart failure compared with patients taking drugs to lower blood sugar.

Medmonitor

Generic Saxenda Delivers First GLP-1 Generic for Obesity

The approval of generic liraglutide injections address increased demand for GLP-1 receptor antagonist drugs.

Medmonitor

FDA Requires New Kidney Injury Warning for All GLP-1 Drugs

Dehydration from these drugs can lead to kidney damage, requiring hemodialysis treatment.

Blog

The Skinny on Weight Loss Drugs and Workers’ Comp

Weight loss drugs are surging in popularity and making their way into workers’ comp. Get the latest news on payer coverage, drug shortages, and costs.

Healthe Developments

Video Spotlight: How Obesity Can Complicate Workplace Injuries

Silvia Sacalis, VP of Clinical Services, chats with Business Insurance.

Medmonitor

FDA Declares Semaglutide Shortage Over

The GLP-1 receptor agonist has been considered in shortage since 2022, but the FDA confirmed with manufacturers that presented and projected demand can now be met.

Medmonitor

FDA Considers Policy Changes for GLP-1 Compounds

Tirzepatide was no longer considered in shortage, removing compounding privileges, until litigation remanded the decision.

This Month's Must Read

Removing Barriers to Recovery: A Primer on Psychosocial Treatments for Injured Workers

The benefits of different screening strategies and therapeutic interventions.

Blog Workers Comp

A Weighty Matter: Obesity and Workers’ Compensation

Obesity has many implications for injured workers, from being a catalyst for injuries to increasing healthcare costs and lengthening time away from work.